Vaccine-Derived Polioviruses, Central African Republic, 2019
| dc.creator | Joffret, Marie-Line | |
| dc.date.accessioned | 2025-08-28T17:11:22Z | |
| dc.date.issued | 2021-02 | |
| dc.description.abstract | Since May 2019, the Central African Republic has experienced a poliomyelitis outbreak caused by type 2 vaccine-derived polioviruses (VDPV-2s). The outbreak affected Bangui, the capital city, and 10 districts across the country. The outbreak resulted from several independent emergence events of VDPV-2s featuring recombinant genomes with complex mosaic genomes. The low number of mutations (<20) in the viral capsid protein 1-encoding region compared with the vaccine strain suggests that VDPV-2 had been circulating for a relatively short time (probably <3 years) before being isolated. Environmental surveillance, which relies on a limited number of sampling sites in the Central African Republic and does not cover the whole country, failed to detect the circulation of VDPV-2s before some had induced poliomyelitis in children. | |
| dc.identifier.other | pasteur-03122581 | |
| dc.identifier.uri | https://hal.science/pasteur-03122581 | |
| dc.identifier.uri | https://africarxiv.ubuntunet.net/handle/1/7508 | |
| dc.language.iso | en | |
| dc.subject | African Research | |
| dc.title | Vaccine-Derived Polioviruses, Central African Republic, 2019 | |
| dc.type | Academic Publication |
